AI Surgical Planning System SurgiPlan Approved by FDA: 3D Patient Organ Reconstruction and Surgical Path Simulation
Surgical Theater's AI surgical planning system SurgiPlan gains FDA approval, automatically reconstructing 3D patient organs from CT/MRI imaging and simulating multiple surgical approaches to recommend optimal plans.
Surgical Theater announced on December 22 that its AI surgical planning system SurgiPlan has received FDA approval. SurgiPlan can automatically perform 3D organ reconstruction from patient CT and MRI images, then simulate multiple surgical approaches and operational plans through AI to recommend optimal surgical paths.
In Cleveland Clinic's clinical validation, surgical teams using SurgiPlan achieved 25% reduction in complex hepatobiliary surgery time, 35% reduction in intraoperative blood loss, and 20% decrease in postoperative complication rates. Surgeons said SurgiPlan allows them to "rehearse" the entire procedure before surgery, greatly enhancing surgical confidence and precision.
Disclaimer
Content is AI-generated. Do not use it as a basis for real decisions. Do not cite it as factual reporting.